Biotech

We know biotech

Let's face it. The biotech industry operates faster, more nimbly and efficiently than pharma. It needs a communications partner built to match. That’s why we carved out a specialty practice within our global platform dedicated to corporate communications for biotech and life science companies.

We are the trusted partner for communicating the awe-inspiring, life-changing scientific and biomedical advancements of our time.

Whether you are a start-up with limited needs, on the verge of an IPO or gearing up for late-stage data, we can scale our team and offering to meet the needs of companies at any stage.

Biotech capabilities
 

Our capabilities

Our areas of expertise

Startup & Launch

Corporate positioning, press release development, media strategy, and social media content to propel your story as you launch from stealth.

Branding

Establish a strong brand that will stand the test of time or reimagine your brand to reflect your company’s evolution.

IPO Comms

Everything you need to successfully make the private-to-public transition, including the investor presentation and materials, tactical investor relations, and corporate communications best practices.

Clinical Trial Recruitment

Communications strategies to take your trial from first patient dosed to fully enrolled, including branding, website, media outreach, and content to raise awareness and engagement with patients and physicians.

Internal & Employee Comms

Powerful campaigns that highlight your purpose and culture to attract and retain top talent.

Patient Advocacy & Engagement

Communications strategies to engage with advocacy organizations and patients to raise awareness of your company’s work and demonstrate your commitment.

Crisis Comms

Scenario planning and rapid strategic responses tailored to address the expected and unexpected issues that could impact your organization.

Biotech leadership team

Carin Canale-TheakstonExecutive Biotech Advisor
Jason SparkPresident, Biotech
Heidi Chokeir, PhDEVP, Biotech
Ian StoneEVP, Biotech

Communications doesn’t just enable corporate strategy, it drives it. It is one of the most powerful tools biotech companies have to build shareholder value. It's an exciting time to partner with innovators on their way to creating a healthier world.

Jason Spark
President, Biotech
Let’s make health more human™